Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683267 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement
A Phase 2 study, sponsored by Anesiva.
- Terminated
- Registry status
- Phase 2
- Development phase
- 118
- Enrollment target
NCT00683267: Clinical Trial Phase 2 study, sponsored by Anesiva.
NCT00683267 is a Phase 2 study that was terminated before completion, run by Anesiva. The registered enrollment target is 118 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (11% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00683267, a Phase 2 study, was terminated before completion, sponsored by Anesiva.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 118 participants
- Enrollment target
Study Summary
Evaluate the efficacy, safety and tolerability of a single intraoperative dose of 4975 in patients undergoing total hip replacement
Interventions
- DRUG Placebo
- DRUG 4975, highly purified capsaicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Why NCT00683267 stopped before completion
NCT00683267 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (11% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00683267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00683267 about?
NCT00683267 is a clinical study titled "Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement". Evaluate the efficacy, safety and tolerability of a single intraoperative dose of 4975 in patients undergoing total hip replacement
What is the current status of trial NCT00683267?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 118 participants. The study started on 2007-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00683267?
The interventions under investigation include: Placebo (DRUG), 4975, highly purified capsaicin (DRUG).
Who is sponsoring clinical trial NCT00683267?
This trial is sponsored by Anesiva, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00683267's enrollment target sits among peer trials
118 618th of 2000 higher than 1,378 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia